Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
id like ten minutes with both of them no holds barred
problem is the sec will confiscate the money and keep it
dales cash haul should go to the injured shareholders. that pos lied and stole the money. and durrant helped him do it .
they both lied their asses off
Only thing worth following and keeping up to date is any development in the case of SEC v. Dale Chappell et al. And the manner in which Dale will hopefully be violently disengorged of his ill-gotten gains on the back of naive investors such as us. Not worth even discussing or giving heed to schizo-based illusions.
We know that the Appeals Hearing has been terminated, and that the District Court case remains sealed pending the resolution of which items will continue to remain sealed. In the bankruptcy court case, we also know, "Status: On July 30, 2024, the Court entered an order resolving this matter.
Accordingly, a hearing on this matter is no longer necessary."
see pg 1/9
https://document.epiq11.com/document/getdocumentsbydocket/?docketId=1105685&projectCode=HUM&docketNumber=340&source=DM
I think management may have survived the lawfare, and may go on the offensive in that regard.
I don't see an immediate distinction between future and current shareholders.
Then you are truly lost and I am saddened that you are ensnared in an illusion of your own making.
My one earnest attempt to guide you toward reason and clarity seem to have faltered against the walls of your alternate reality.
Best of luck to you, and I am so sorry to all of those who lost in this scam.
If they planned on rewarding shareholders they would not have cancelled the stock making it worthless! They rewarded the shorts and their own insiders by not forcing them to cover their positions.
They are rewarding future shareholders if Lenz succeeds, current holders get nothing.
No one from management gives a shit about you or any shareholders losses, I’m sorry, they will reward themselves though, that’s how this market works.
My conscience is clear. I am also undaunted in expressing my assessment of our reality.
Contrary to a popular mantra, the truth doesn't always make you free. I think management is fully prepared to evidence the truth, and to see justice prevail, and to see shareholders rewarded.
The only madness I am trying to stop is the government's abuse of discretionary authority.
Jay, not sure why you continue to troll with these incredulous posts. These poor investors have lost a lot of money, with some claiming losses in the 7 figure range.
It’s time to face reality or your conscience. Please realize that your actions are unhealthy for both you and the victims of this scheme fka humanigen, fka kalobios. Please stop this madness and seek help if you can, I urge you.
None of which will have any effect on the disastrous formerly HGEN shares taking useless space in our portfolios.
But yay Lenz is amazing and will save the world and make Durrant and the other scumbags even richer.
I think we'll all be glad that we invested here. There's more potential here than I routinely talk about, but I think we could benefit by our relationship to Mayo Clinic, and I think former Board Members Hohneker and Xie will develop lenz and ifab for ArriVent and AstraZeneca. In addition, there is the rather inconvenient fact that there are no medical countermeasures to prevent or treat a virulent form of coronavirus, or another type of virus altogether.
Don't ever listen to Jay. He lives in some weird alternative universe. Sponge and now Humanigen. Dude needs to let someone else invest his money
No, you didn't miss anything. My discussion of Novavax, and Sanofi, represents my own conclusions. What little indication I have seen that I may be right are the co-licensing and manufacturing agreements there have subsequently been between the two companies, to include Sanofi using the Novavax vaccine as part of their Covid Influenza Combination (CIC) vaccine. That market is reportedly twice as large as the covid market.
“The world needs the lenz-enhanced Novavax covid vaccine.”
If I remember correctly, you have hoped and assumed Lenz was in the Novavax Covid vaccine? Did I miss this becoming confirmed and verifiable?
I noted previously that Novavax concentrated on obtaining regulatory approvals worldwide, before they even thought of applying for an EUA in the US. Smart CEO. And after they finally did apply for an EUA, I recall that the FDA wanted to see more data. I assume NVAX provided additional data from an alternate universe, but however they did it, they got additional information for the FDA to award their first EUA. Subsequent yearly EUA awards were not authorized until after the mRNA vaccines were approved. That happened again for this 2024-2025 current vaccine flavor.
"August 22, 2024
Updated August 23, 2024
Novavax and the U.S. Food and Drug Administration (FDA) are working together productively as the U.S. FDA continues its review of data in consideration of an Emergency Use Authorization (EUA) of Novavax’s 2024-2025 formula COVID-19 vaccine (NVX-CoV2705)."
https://ir.novavax.com/press-releases/Novavax-Continues-to-Work-with-the-US-FDA-on-Authorization-of-2024-2025-Formula-COVID-19-Vaccine
Once the mRNA vaccines had first-to-market access, NVAX was authorized.
Novavax 2024-2025 Formula COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S.
August 30, 2024
https://ir.novavax.com/press-releases/2024-08-30-Novavax-2024-2025-Formula-COVID-19-Vaccine-Now-Authorized-and-Recommended-for-Use-in-the-U-S
Dr. John just released a new video in this regard, with information from Florida.
"On August 22, 2024, the United States Food and Drug Administration (FDA) approved and authorized updated versions of mRNA vaccines from Pfizer-BioNtech and Moderna.
"The FDA approved the vaccine for people 12 and older and provided emergency use authorization for children 6 months to 11 years old.
•Unvaccinated individuals 6 months through 4 years of age are eligible to receive three doses of the updated, authorized Pfizer-BioNTech COVID-19 Vaccine or two doses of the updated, authorized Moderna COVID-19 Vaccine."
The Florida Surgeon advised against the use of mRNA vaccines. Dr. John provides the data in support of this decision.
But what a mess! And the price could be paid even from infants only six months old.
I have not seen A.I. replace customer service online chats so far..so this A.I. in my opinion is rubbish.
and wasting people time chatting with A.I. as customers service as it's just random answers replies based on words you ask. that is A.I>?
and A.I. is auto generated chat talk like Jay.
notice Cowtown jay keeps talking the medical studies and nothing more.
jay could be more advance A.I. too.
cowtown is just randomly generated postings. and they call this A.I.
it's like those fake chats in custome service, it's basically random replies to questions and the A.I. replies to questions based on word you type. it's not even A.I.
the lawsuit was selling hopium. there is no hope and if the 'shareholders' didn't sue the company, the shares and the company would not need to go bankrupt. they wanted to go bankrupt so the shares are worthless. what don't you understand. no invesement company will invest in a company that is being sued by their own shareholders and managment and people operating this operation of company is 'shady' and have criminal connnections you know what I mean. every gov't insittuion is now 'corrupted' that is something the 'gov't censored and controlled media won't report because it's CENSORED. or self censorship, known in the streets as 'code of silence' and anyone who dare to speak out is fired,,literally or something band happens to them like accidental death or overdose tc.
the 'shareholder' LAWSUIT was created so it gave the company and EXCUSE to go bankrupt. it had 3 million in the bank and a shareholder LAWSUIT would scare any investor who would invest in the company and it was the reason the shares went from $20 to .0001. the controlling shareholder already sold his shares via short positions which why jay still sees naked shares not delivered or lots of shares were loaned to a short.
the retail investors or peons were call useful idiots like jay for playing along with the scam. the judge may approved the 3 million 'settlement' but you won't get a dime of that money. so you wasted your time as for the law firm who filed,,they obviously was paid by someone as lawyers never work 'free' and always want a retainer fee. even if you lose. or don't get any money from lawsuit. or someone paid them to ask for shareholders to file the 'lawsuit' or complaint.
Lenzilumab ought to be considered as one of the key Mabs evaluated by the ReVAMPP pandemic preparedness network. Lenz should be evaluated both as a therapeutic, as well as a vaccine enhancement.
Of course, distinctive selection of lenz for the ACTIV-5 Bet-B trial was achieved, to no avail. So the NIH AND management would have to agree on patient parameters for trial inclusion.
"Friday, September 13, 2024
NIH awards establish pandemic preparedness research network
Scientists will work on high-priority pathogens most likely to threaten human health."
https://www.nih.gov/news-events/news-releases/nih-awards-establish-pandemic-preparedness-research-network
thanks ..i have extremely low expectations unfortunately
Hopefully you’ll receive something.
i took the time to put it together and send it out , have not heard a word
Not me. I spent about 4 hours gathering all the info. Submitted everything on time. Received a letter from the law firm recently saying I didn’t provide all the necessary documentation. There was nothing else to give them. I documented all the buys and sells. They gave me a short time to respond or I receive nothing. I didn’t reply.
has anyone gotten any money on the 3mm ?
asking for a friend
i saw lenzilumab being sold for 50 bucks a vial lol. at least durrant can get lunch money off the inventory we paid for
You can’t merge stock when the shares are cancelled, there is nothing to merge! If they wanted shorts to cover they wouldn’t have cancelled the shares, they don’t have anything to cover.
I don't see where he stole anything from Humanigen shareholders. We still hold the covid patents.
https://patents.justia.com/assignee/humanigen-inc
And Taran still shows being assigned the CAR-T patents only.
https://www.plainsite.org/patents/assignment.html?id=11607371
For all I know, the rights Taran has for lenz may only relate to manufacturing and commercialization, for now.
I think the company is ready to announce a stock merger with Taran (or Humanigen Australlia), which was completed prior to the shares being dissolved. I think this will force a buy-in of Taran (or HA) shares to cover Humanigen shares held short.
I will not be surprised to see the merger news, along with regulatory approval of CMML, and possibly news regarding Sanofi and Novavax, tonight. I think we would have seen this news a few weeks ago, if the FDA hadn't delayed the Novavax authorization. I'm only saying this because you asked about what I expect, so now you know. This could be delayed if the District Court case remains totally sealed, so I would at least like to see partial case data, relating to management, unsealed.
jay if you go on the taran website they are actively selling the drug and moving forward. the only mention of humanigen is that taran purchased the assets of the company.
wondering when you expect durrant to show his merciful side and grant to the shareholders what he stole from the shareholders with shareholders money
Thank you for the 👍️, rjurko! I think management has more than just earned my continued confidence. I think I'm fixin' to be sincerely grateful to them for the bountiful reward they will make possible for me, and all shareholders. It looks to me like we are ready to succeed.
I have an expanded view of the facts in this case. I see no reason to take my focus off the graft and corruption of the US government agencies, and their Big Pharma benefactors/beneficiaries who have a role in this case. I have increasing confidence that our management team of Medical Doctor/MBA's, are on the right track, both to succeed, as well as to hold all parties guilty of malfeasance accountable for their actions.
As much as I hate to say this about another person, you are correct.
I feel for him here , but the reality is he is in complete denial of the true situation and refuses to separate his belief about the product from the facts of the scenario.
I do feel sorry for cow, he is living in some weird universe
If it was shell company we would at least have a chance at something. Shares are cancelled and will never have value or trade again.
My accounts no longer have the ticker symbol, it's just a bunch of numbers. Shell company status
It doesn't matter cowtown, the company is BK and the shares are worthless
Durrant once described the FDA as our collaborative partner. Later, he also claimed that withholding our regulatory authorization had cost tens of thousands of preventable deaths.
I don't think either statement remains accurate.
There probably are cooperative FDA employees who work with company executives in the design of their clinical trials. And I would not be surprised if management had productive working relationships with FDA employees in that group. But it appears that they are lower in the hierarchy than the FDA group that has authorization responsibility. That group granted themselves the power to Decline to award our EUA, despite the two peer reviews that made it impossible for them to Deny our EUA. That newly self-granted discretionary authority, which effectively kept lenz off the market without an insupportable Denial, should be rescinded, and the group that Declined to make a regulatory decision to approve the EUA should be fired and/or charged for failing to grant our EUA.
The tens of thousands of preventable deaths that Durrant claimed is a far cry from the tens of millions of covid deaths now being reported by some researchers. But Durrant was only referencing the preventable deaths that occurred from the time of our Declination, until the time of his comment. Nevertheless, that is STRONG language for a CEO to use against the FDA. But he did not back down from making the claim, and I think the abuse of discretionary authority by government agencies is part of the claims in the sealed District Court case.
So yes, I'm looking for the little guys to bring down the system.
Set us up perfectly? Dude we have worthless shares that have been cancelled! Yeah that’s great they sure are going to stick it to the man! Cheers to the little guy who is going to bring down the system lol.
It looks like management has us perfectly set-up. I can only hope that charges are filed by the IG/FBI against Pfizer, BioNtech, Moderna, NIAID, the NIH, the FDA, etc. The abuse of discretionary authority by unelected government bureaucrats has resulted in severe damage to Humanigen and the shareholders. But more importantly, it has resulted in the significant loss of lives that could have been saved by lenzilumab.
Peer-reviewed research in the International Journal of Vaccine Theory, Practice, and Research, found that "Our observations suggest the presence of some kind of nanotechnology in the COVID-19 injectables."
Some of the slides look like aerial photographs of earth works 'Time Team' archaeologists use in the UK when they are searching for Bronze Age castles, moats, etc. One slide looked like a schematic of an industrial spray booth gun.
You can view Dr. John's presentation of the data here.
"I'm looking forward to the realization that the status quo has changed, and that the IMPACT group, SAHMRI, Novavax, and Sanofi will redefine the requirement for lenzilumab, and that we will partner or merge with them, and fulfill the reason for the bankruptcy judge's amendment to the Asset Purchase Agreement."
I think we're ready.
I hope the reappearance of a monetary value for our shares portends that a merger is finally in play.
I see that the monetary loss is once again being reflected on my Humanigen shares, instead of that amount being "N/A."
"I suspect that circumstances in this case indicate malfeasance by the FDA, NIAID, the NIH, and the SEC, as well. I can't see any other reason that this case remains sealed."
I hope that state AG's, like Ken Paxton of Texas, have initiated or joined a criminal investigation of the government's graft and corruption in this case, which remains sealed, even though management's role appears to have been litigated. God help us if the FBI is the sole criminal investigator.
I'm surprised that Sanofi hasn't leveraged the PREACH-M and RATinG studies, and pushed for regulatory approval of lenz from Australia. We should be seeing the interim analysis of lenz from the RATinG study at any time.
OK I agree with you -FDA is a scum bag thats a given
I would love to get on with my life, with the full measure of success that I may deserve. But right now, "My focus is on the fact that preventable deaths are occurring everyday."
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174897470
There are a reported 31M people who have suffered "excess" deaths, including the 17M who died of covid vaccine-related complications. Why not do what we can to allow future victims to also get on with their lives?
C'mon man move on with your life get off of this board
"FDA Authorizes Updated Novavax COVID-19 Vaccine..."
https://www.fda.gov/news-events/press-announcements/fda-authorizes-updated-novavax-covid-19-vaccine-better-protect-against-currently-circulating
I hope this news proves to be relevant, perhaps even pivotal, for Humanigen and Sanofi.
The allegations in this sealed case are denied. That's one of the facts in this case. But I looked at our path, based on your assertion that the shell is defunct, which I still can't accept, and even if you are correct, we still have a path forward. So I, too, will continue to outline facts from my pro-management perspective. They deserve nothing less than all the support that I can give them.
Followers
|
326
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
43360
|
Created
|
01/31/13
|
Type
|
Free
|
Moderators DTGoody cowtown jay |
Humanigen, Inc. is a clinical-stage biopharmaceutical company developing its portfolio of next-generation cell and gene therapies for the treatment of cancers via its novel, GM-CSF neutralization and gene-knockout platforms. As a leader in GM-CSF pathway science, we believe that we have the ability to transform CAR-T therapy and a broad range of other T-cell engaging therapies, including both autologous and allogeneic cell transplantation. There is a direct correlation between the efficacy of CAR-T therapy and the incidence of life-threatening toxicities (referred to as the efficacy/toxicity linkage). We believe that our GM-CSF neutralization and gene-editing platform technologies have the potential to reduce the inflammatory cascade associated with serious and potentially life-threatening CAR-T therapy-related side effects while preserving and potentially improving the efficacy of the CAR-T therapy itself, thereby breaking the efficacy/toxicity linkage. Clinical correlative analysis and pre-clinical in vivo evidence points to GM-CSF as the key initiator of the inflammatory cascade resulting in CAR-T therapy’s side-effects. Pre-clinical in vivo data on the neutralization of GM-CSF using antibody or gene KO indicates that it is not required for CAR-T cell activity. Our strategy is to continue to pioneer the use of GM-CSF neutralization and GM-CSF gene knockout technologies to improve efficacy and prevent or significantly reduce the serious side-effects associated with CAR-T therapy.
We believe that our GM-CSF pathway science, assets and expertise create two technology platforms to usher in next-generation CAR-T therapies. Lenzilumab, our proprietary Humaneered® anti-GM-CSF immunotherapy, has the potential to be used in combination with any FDA-approved or development stage CAR-T therapy, as well as in combination with other cell therapies such as HSCT, to make these treatments safer and more effective. In addition, our GM-CSF knockout gene-editing platform has the potential to create next-generation CAR-T therapies that may inherently avoid any efficacy/toxicity linkage, thereby potentially preserving the benefits of the CAR-T therapy while altogether avoiding its serious and potentially life-threatening side-effects.
The company’s immediate focus is combining FDA-approved and development stage CAR-T therapies with lenzilumab, the company’s proprietary Humaneered® anti-human-GM-CSF immunotherapy, which is its lead product candidate. A clinical collaboration with Kite, a Gilead Company, was recently announced to evaluate the use of lenzilumab with Yescarta®, axicabtagene ciloleucel, in a multicenter clinical trial in adults with relapsed or refractory large B-cell lymphoma. The company is also focused on creating next-generation combinatory gene-edited CAR-T therapies using strategies to improve efficacy while employing GM-CSF gene knockout technologies to control toxicity. The company is also developing its own portfolio of proprietary first-in-class EphA3-CAR-T for various solid cancers and EMR1-CAR-T for various eosinophilic disorders. The company is also exploring the effectiveness of its GM-CSF neutralization technologies (either through the use of lenzilumab as a neutralizing antibody or through GM-CSF gene knockout) in combination with other CAR-T, T cell engaging, and immunotherapy treatments to break the efficacy/toxicity linkage including the prevention and/or treatment graft-versus-host disease (GvHD) in patients undergoing allogeneic HSCT. The company has established several partnerships with leading institutions to advance its innovative cell and gene therapy pipeline.
June 15, 2020
Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Hospitalized Patients With COVID-19 Pneumonia
https://clinicaltrials.gov/ct2/show/NCT04351152
Anti-GM-CSF antibodies expected to show better effect in Covid-19 than cytokine-specific targets
July 27, 2020
https://discoverysedge.mayo.edu/2021/06/22/cancer-to-covid-19/
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |